ISRG Intuitive Surgical Inc. Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
19:04
Jul 17
Jul 17
Intuitive Surgical shares fell despite a Q2 revenue beat due to domestic growth concerns and a Stifel price target cut, with the Seeking Alpha Quant score at neutral HOLD.
12:34
Jul 17
Jul 17
US pre-market movers show broad declines led by semiconductor and tech ETFs on competitive pressure from Moonshot AI, while Alcoa, SpaceX, Intuitive Surgical, Autoliv, and SouthFirst Bancshares all fell on earnings or operational misses.
12:16
Jul 17
Jul 17
Premarket movers show Mag 7 stocks and chipmakers all lower amid a broad tech selloff, with Autoliv, Intuitive Surgical, Netflix, and Staar Surgical all falling on earnings-related news.
01:55
Jul 17
Jul 17
Intuitive Surgical shares fell as much as 13% in after-market trading after growth in da Vinci robot use slowed to its weakest pace in four years and procedure guidance remained unchanged.
22:41
Jul 16
Jul 16
Intuitive Surgical reported strong Q2 2026 results with revenue up 19 percent to 2.89 billion dollars driven by da Vinci 5 and ION adoption.
20:07
Jul 16
Jul 16
Intuitive Surgical reports second-quarter revenue and adjusted earnings above analyst estimates and forecasts full-year da Vinci procedure growth near the midpoint of its guidance range.
11:56
Jul 16
Jul 16
The author provides a comprehensive macro and market brief highlighting geopolitical escalation, consumer deterioration, and technical fragility from gamma expiry and buyback blackout without stating any personal positions or forward calls.
14:00
Jul 14
Jul 14
Healthcare sector rotation for midterms.
Healthcare is set to dramatically outperform. The sector has fallen from 16-17% of the S&P 500 to just 8%, and a rotation is underway as midterm election dynamics favor Democrats and fiscal hawks. The firm has gone long healthcare, highlighting Intuitive Surgical and Baxter.
MED
21:06
Jul 12
Jul 12
The author reflects on past ownership and curiosity about Intuitive Surgical but expresses no current position or forward-looking trade idea.
LOW
20:31
Jul 12
Jul 12
The author shares a humorous bracket contest mention and lists their "Callfolio" holdings as a personal portfolio snapshot without making any forward-looking trade calls or endorsements.
LOW
03:15
Jul 05
Jul 05
Author discloses an active existing long position in Intuitive Surgical (ISRG), confirming current bullish exposure with no stated exit or concern.
MED
01:21
Jul 03
Jul 03
Author describes a balanced core portfolio rebalanced in June 2026 that has outperformed the S&P 500, but the tweet is a retrospective performance update and general advice to stay balanced, not a fresh trade call.
15:54
Jul 02
Jul 02
Long these names as part of a balanced portfolio rebalanced on 6/15 to rotate out of tech into healthcare, financials, energy, and defensives, outperforming SPY by 4x.
MED
13:45
Jun 29
Jun 29
Author identifies Physical AI and Robotics as a potential supercycle and lists these companies as watchlist candidates; no directional commitment.
LOW
20:40
Jun 23
Jun 23
The author is researching the Physical AI value chain and asking for additions to their overview, not expressing any directional positions.
LOW
19:53
Jun 11
Jun 11
Intuitive Surgical data AI advantage buy.
Intuitive Surgical (ISRG) sits on an incredibly valuable proprietary dataset from robotic-assisted surgeries worldwide, positioning it as an AI-driven profit beast over the next 5-10 years. The stock is unloved, underowned, and currently near its 200-day moving average, presenting a screaming buy opportunity.
HIGH
17:29
Jun 11
Jun 11
Intuitive Surgical AI data play, buy
Intuitive Surgical possesses the best proprietary surgical data, positioning it as a future AI profit beast analogous to Tesla's data advantage in autonomous driving. The stock is unloved, underowned, and trading on its 200-week moving average, presenting a screaming buy.
HIGH
10:50
Jun 08
Jun 08
A community member opened a “big bet” on ISRG after years of following the company, expressing high conviction. ISRG is a dominant player in robotic surgery with a durable moat; current entry offers diversification away from overhyped AI names. The upvoted comment endorses ISRG as a long‑term healthcare leader worth buying on dips. Procedure volume variability, regulatory hurdles, and a rich valuation could cap upside.
LOW
17:18
Jun 05
Jun 05
Author discloses a recent purchase of ISRG made Tuesday, now up 6%; no catalyst given, minimal conviction signal from a retail holder's recent buy disclosure.
MED
14:13
Jun 03
Jun 03
Buy ISRG as Piper Sandler field checks confirm bear concerns are overblown — DV5 driving higher utilization without cannibalizing Xi volumes, ASC expansion and cardiovascular procedures are incremental growth drivers, and the company beat top/bottom line last quarter; shares dropped below $400 despite consensus PTs of $520–$651.
MED
02:10
Jun 03
Jun 03
Long quality compounder names ISRG, LLY, MA on the thesis that as AI stocks price earnings further out, these high-quality non-AI growers are increasingly attractive on a relative basis and are being ignored by the market.
MED
17:54
Jun 02
Jun 02
Buy quality non-AI compounders as AI stocks price growth further out, making established growth names like ISRG, LLY, and MA relatively more attractive on a forward-growth-priced-in basis.
MED
16:03
Jun 02
Jun 02
Buy ISRG on price dislocation below $400 despite Piper Sandler's $580 PT; razor-and-blade recurring revenue model, 11,000 installed systems, 10M+ procedures create durable data moat with AI/robotics tailwinds supporting consistent YoY sales growth.
MED
14:01
Jun 02
Jun 02
Buy ISRG as the best healthcare equity play; robotic surgical equipment avoids pharma regulatory/safety risk, and the strong competitive moat justifies a premium valuation despite elevated multiples.
MED
14:44
May 31
May 31
Speaker observes ISRG's autonomous robotics opportunity is underappreciated by the market; no position disclosed, no specific catalyst or entry point stated.
LOW
21:56
May 21
May 21
Long medtech and digital health names as rising semiconductor content in medical devices drives growth in imaging, monitoring, robotics, and wearables.
HIGH
15:31
May 15
May 15
The author implies that non-AI names are broken and will be crushed to zero multiples, signaling a bearish rotation out of traditional stocks into AI.
HIGH
15:30
May 15
May 15
The author expresses frustration with market valuations and poses a rhetorical question about selling AI positions to buy non-AI names, but provides no explicit forward-looking directional call.
HIGH
12:49
May 15
May 15
The author poses a rhetorical question about valuation multiples for non-AI names versus selling AI positions, but offers no explicit directional view or trade recommendation.
HIGH
About ISRG Analyst Coverage
Buzzberg tracks ISRG (Intuitive Surgical Inc.) across 24 sources. 17 bullish vs 0 bearish calls from 23 analysts. Sentiment: predominantly bullish (39%). 44 total trade ideas tracked. Past 7 days: 1 bullish, 7 watch. Latest voices: SeekingAlpha, Newsquawk, zerohedge.